Lopinavir Completed Phase 2 Trials for Human Immunodeficiency Virus (HIV) Infections / Tuberculosis (TB) Other

IndicationsStatusPurposePhase
CompletedOther2
clinicaltrials.gov IdentifierTitleDrugs
https://clinicaltrials.gov/ct2/show/Pharmacokinetics and Safety of Rifabutin 150 mg Once Daily Versus Rifabutin 300 mg Thrice Weekly